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Abstract
Bone marrow-derived cells are known to infiltrate the adult brain and fuse with cerebellar Purkinje cells. Histological obser-
vations that such heterotypic cell fusion events are substantially more frequent following cerebellar injury suggest they could 
have a role in the protection of mature brain neurons. To date, the possibility that cell fusion can preserve or restore the 
structure and function of adult brain neurons has not been directly addressed; indeed, though frequently suggested, the pos-
sibility of benefit has always been rather speculative. Here we report, for the first time, that fusion of a bone marrow-derived 
cell with a neuron in vivo, in the mature brain, results in the formation of a spontaneously firing neuron. Notably, we also 
provide evidence supporting the concept that heterotypic cell fusion acts as a biological mechanism to repair pathological 
changes in Purkinje cell structure and electrophysiology. We induced chronic central nervous system inflammation in chi-
meric mice expressing bone marrow cells tagged with enhanced green fluorescent protein. Subsequent in-depth histological 
analysis revealed significant Purkinje cell injury. In addition, there was an increased incidence of cell fusion between bone 
marrow-derived cells and Purkinje cells, revealed as enhanced green fluorescent protein-expressing binucleate heterokaryons. 
These fused cells resembled healthy Purkinje cells in their morphology, soma size, ability to synthesize the neurotransmitter 
gamma-aminobutyric acid, and synaptic innervation from neighbouring cells. Extracellular recording of spontaneous firing 
ex vivo revealed a shift in the predominant mode of firing of non-fused Purkinje cells in the context of cerebellar inflamma-
tion. By contrast, the firing patterns of fused Purkinje cells were the same as in healthy control cerebellum, indicating that 
fusion of bone marrow-derived cells with Purkinje cells mitigated the effects of cell injury on electrical activity. Together, 
our histological and electrophysiological results provide novel fundamental insights into physiological processes by which 
nerve cells are protected in adult life.
Keywords Fusion · Purkinje cells · Cerebellum · Bone marrow-derived cells · Inflammation
Introduction
Cells that reside within the bone marrow (BM) have long 
been known to fuse with several distinct types of cells 
throughout the body, including brain neurons [2, 41]. 
While the biological function of BM-derived cell fusion 
with neurons is not clear, related experiments involving 
fusion of ‘healthy’ donor BM-derived cells with host 
hepatocytes, to ameliorate metabolic liver disease, have 
provided strong clues for a role in targeted tissue regen-
eration [40, 43]. Within the brain, fusion of BM-derived 
cells occurs predominantly, although not exclusively [10], 
with Purkinje cells of the cerebellum [23]. Morphological 
and mRNA analyses of these fused Purkinje cells reveal 
the formation of either mononucleate cells or binucleate 
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heterokaryons, with subsequent nuclear reprogramming 
and expression of donated nuclear genes [20, 29].
The incidence of BM-derived cells fusing with cerebel-
lar Purkinje cells appears to be very low under normal 
physiological conditions [22, 24, 29]. Nevertheless, its 
biological relevance is suggested by observations that 
such fusion events in either rodents or humans are sub-
stantially increased in number with age [41, 42]; or after 
exposure to cytotoxic agents (for example radiation or 
chemotherapeutics) [26, 42]; or within an inflammatory 
microenvironment such as that present in multiple scle-
rosis [22] and in animal models of cerebellar disease [9, 
10, 13, 20, 21, 29]. These observations have been taken to 
suggest that, as Purkinje cells are generated only during 
early cerebellar development [28], heterotypic cell fusion 
(fusion between different cell types) acts as a physiologi-
cal cell rescue mechanism to counter neuronal injury and 
maintain Purkinje cell function throughout adulthood. 
Purkinje cells are some of the largest, most complex and 
elaborate neurons in the human brain; their axons repre-
sent the sole output for conveying nerve impulses from 
the cerebellar cortex, and as such, they are an essential 
part of the motor system [8]. Their loss is characterised 
clinically by insidious accumulation of disability [27]. 
If heterotypic cell fusion attenuates neuronal cell dam-
age and prevents Purkinje cell dysfunction, it may have 
valuable therapeutic implications for neurodegenerative 
disease in general, and in particular, for patients with cer-
ebellar injury.
The notion that fusion of BM-derived cells with adult 
Purkinje cells preserves or restores function in the face 
of injury currently remains an attractive, even likely, 
hypothesis. However, there is no direct experimental evi-
dence of cellular repair; functional restoration in Purkinje 
cells has never been directly tested by assessing the cell 
morphology or electrical activity of the fused cells, or 
by comparing the properties of these cells with those of 
damaged Purkinje cells that have not undergone fusion 
with BM-derived cells or with Purkinje cells in healthy 
control animals. At a more fundamental level, it is not 
even known if an adult brain neuron that has fused with 
a different type of cell remains capable of firing action 
potentials; studying and elucidating these aspects of cell 
fusion in the adult brain is challenging. In an attempt to 
address these outstanding and crucial questions, we uti-
lize an in vivo central nervous system (CNS) inflamma-
tory disease model in chimeric mice expressing enhanced 
green fluorescent protein (EGFP)-BM cells. We perform 
both detailed histological and electrophysiological analy-
sis of single Purkinje cells ex vivo in adult cerebellar 
slices, to assess the physiological role that cell fusion 
plays in neuronal protection in the adult brain.
Materials and methods
Animals
All animal experiments were performed in accordance 
with the UK Animals (Scientific Procedures) Act 1986 and 
approved by the University of Bristol Animal Welfare and 
Ethical Review Body. All animal numbers are based on 
both previous experience and/or power calculations using 
preliminary data. Blinding could not be performed when 
comparing Purkinje cells that had or had not fused with BM-
derived cells due to reliance on EGFP to identify fused cells.
Transgenic mice ubiquitously expressing EGFP (strain # 
C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ, stock # 006567) 
were purchased from Jackson Laboratory, USA. Wild-type 
C57BL/6 VAF/Elite mice were provided by Charles River, 
UK. All mice were housed in a specific pathogen-free facil-
ity, with free access to food and water. If subject to a bone 
marrow transplant (BMT), mice were maintained in filter 
top cages (pore size 100 μm) during the recovery period.
Bone marrow transplantation: generation 
of EGFP‑expressing BM chimeric mice
Donor BM cells were harvested, under sterile conditions, 
from 10 to 12 week old male C57BL/6 EGFP-expressing 
transgenic mice [Tg(CAG-EGFP)131Osb/LeySopJ; Jack-
son laboratories, USA]. Briefly, mice were euthanized by 
cervical dislocation and BM cells harvested by gently flush-
ing both their femurs and tibias (using a 27G needle) with 
phosphate buffered saline (PBS) (pH 7.4), 2% foetal bovine 
serum (FBS), 1% Penstrep, 10 units/ml heparin. Cells were 
subsequently passed through a 40 µm cell strainer, washed 
twice in PBS (pH 7.4) by centrifugation at 600g (10 min), 
and re-suspended in PBS to give a final concentration 
of ≥ 1 × 107 cells/150 µl. Young adult female recipient wild-
type C57BL/6 mice (aged 12 weeks) were irradiated, with 
a single dose of 1000 rad from a 137Cs source, 6 h prior 
to receiving 1 × 107 unfractionated EGFP-expressing BM 
cells by tail-vein injection (there are well-established dif-
ferences in the radiosensitivity of different inbred mouse 
strains [14]; C57BL/6 mice typically require a single dose 
of 900–1100 rad to achieve both complete myeloablation 
and high levels of BM engraftment). Sterile water, antibiot-
ics (Baytril), sterile food and bedding were all provided for 
4 weeks post-transplant.
Detection of chimerism
At 12 weeks post BMT (female animals aged 24 weeks), 
haematopoietic reconstitution was evaluated in peripheral 
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blood by flow cytometry (FACSCalibur, Becton–Dickinson). 
Briefly, 100 µl of peripheral blood was harvested from the 
tail vein and suspended in PBS [pH 7.4; ethylenediamine-
tetraacetic acid (EDTA), 2 mg/ml]. Red cells were removed 
using red cell lysis buffer, and the remaining nucleated cell 
population was re-suspended in PBS, 3% FBS and exam-
ined for EGFP expression when excited at 488 nm using 
flow cytometric analysis. Peripheral blood harvested from 
a non-transplanted C57BL/6 mouse was used as a reference 
control. Data were evaluated using BD Cellquest™ software.
Induction and evaluation of experimental 
autoimmune encephalomyelitis (EAE)
At 18 weeks post BMT, mice (female, now aged ~ 30 weeks) 
were immunised by subcutaneous injection, at the base of 
the tail, of 100 µl of a sonicated emulsion containing equal 
volumes of complete Freund’s adjuvant (CFA) (Difco) and 
PBS containing 200 µg myelin oligodendroglial glycoprotein 
(MOG) peptide p35–55. CFA was supplemented with 4 mg/
ml of heat-killed Mycobacterium tuberculosis (Difco). Per-
tussis toxin (Sigma Aldrich, P2980) (200 ng) was adminis-
tered intraperitoneally in 500 µl of PBS directly after immu-
nisation and again 48 h later. Individual mice were assessed 
twice daily for clinical signs of EAE using the following 
scoring system: 0, no disease; 1, flaccid tail; 2, hindlimb 
weakness and/or impaired righting; 3, hindlimb paralysis; 
4, hind and forelimb paralysis; 5, moribund.
Cerebellar slices
All female mice were culled aged between 9.5 and 
11.5 months (~ 10 to 20 weeks after EAE induction), in 
accordance with the United Kingdom Animals (Scientific 
Procedures) Act 1986 and the University of Bristol Ani-
mal Welfare and Ethical Review Body. Parasagittal slices of 
cerebellar vermis (225 µm) were cut on a Leica VT1000S 
vibrating microtome (Leica Microsystems, Nussloch, Ger-
many) in ice-cold solution (in mM: 62 NaCl, 124 sucrose, 
1.3  MgSO4, 5 KCl, 1.2  KH2PO4, 26  NaHCO3, 10 D-glucose, 
2.4,  CaCl2, pH 7.4, bubbled with 95%  O2, 5%  CO2). They 
were stored in standard Krebs–Henseleit solution (in mM: 
124 NaCl, 1.3  MgSO4, 5 KCl, 2.4  CaCl2, 1.2  KH2PO4, 26 
 NaHCO3, 10 d-glucose, pH 7.4, bubbled with 95%  O2, 5% 
 CO2) at room temperature for 1–8 h prior to extracellular 
recording from Purkinje cells. After recording, each cer-
ebellar slice was fixed in 4% paraformaldehyde in PBS for 
18 h at 4 °C and subsequently stored in PBS containing 
0.1% sodium azide at 4 °C prior to immunohistochemistry. 
Cerebellar slices not used in extracellular recording were 
also fixed in 4% paraformaldehyde in PBS for 18 h at 4 °C 
and subsequently stored in PBS, 0.1% sodium azide at 4 °C. 
Slices were also made from female, age-matched control 
mice (9.5–11.5 months, C57BL/6 VAF/Elite).
Immunohistochemistry and imaging
When required, cerebellar slices stored in PBS, 0.1% sodium 
azide were washed in PBS. For immunofluorescent labelling, 
non-specific binding was blocked with 10% normal goat/
donkey serum diluted in PBS containing 0.1% triton. Sec-
tions were incubated at 4 °C overnight with primary anti-
bodies to calbindin-D28K (Sigma-Aldrich; C2724 1:500), 
CD11b/c (Abcam; ab1211 1:100), EGFP (Abcam; ab6556 
1:500 and Abnova; MAB1765 1:1000), glutamic acid decar-
boxylase (GAD) (Abcam; ab11070 1:1000); myelin basic 
protein (MBP) (Serotec; MCA4095 1:100); synaptophysin 
(Dako; M7315), SMI-34 (Biolegend; 835503 1:500); zebrin 
II (kindly donated by Prof. Izumi Sugihara, Tokyo Medical 
and Dental University, Tokyo, Japan [39]). Sections were 
washed in PBS and incubated for 45 min in the dark with 
Alexa Fluor 488/555—goat/donkey anti-mouse (1:500),—
goat/donkey anti-rabbit (1:500),—goat/donkey anti-rat 
(1:500) secondary antibodies (Invitrogen, Paisley, UK), and 
then mounted in Vectashield medium containing the nuclear 
dye 4′6′-diamidino-2-phenylindole (DAPI) (H-1200, Vector 
Laboratories).
A proportion of the cerebellar slices stored in PBS, 0.1% 
sodium azide were first embedded in paraffin for sectioning 
(8 µm) on a rotary microtome (Leica LM2135) and mount-
ing on glass slides. Sections were deparaffinised in clearene, 
dehydrated in 100% ethanol and hydrated in distilled water. 
Antigen retrieval was performed, through boiling the sec-
tions in sodium citrate buffer (0.01 M, pH 6.0, 5 min), prior 
to immunofluorescent labelling (as described above). Confo-
cal microscopic analysis was performed using either a Leica 
SP5-AOBS confocal laser-scanning microscope attached to 
a Leica DMI6000 inverted epifluorescence microscope or 
a Nikon C1 confocal microscope and EZ viewer software 
(Nikon). All Z-stack and three-dimensional imaging was 
created using Leica Application Suite Advanced Fluores-
cence software (Leica Biosystems) followed by Volocity 3D 
image software (PerkinElmer, USA).
In situ hybridization
Cerebellar slices were embedded in paraffin for section-
ing (8 µm) on a rotary microtome (Leica LM2135) and 
mounting on glass slides. Sections were deparaffinised 
in clearene, dehydrated in 100% ethanol, and placed in 
0.2 M HCl for 20 min. The sections were washed in water 
and subsequently in 2× saline-sodium citrate (SSC) buffer 
before immersion in 10 mM citric acid (pH 6.0) at 80 °C 
for 2 h. After washing with water and then 2× SSC buffer, 
proteins were digested for 2 min at 37 °C using pepsin 
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A (Digest-All 3 protease, Invitrogen). The sections were 
washed in water, dehydrated through an ethanol series and 
air dried. Fluorescent in situ hybridisation (FISH) probes 
(mouse control X and Y probes; Empire genomics, New 
York, USA) were prepared according to the manufactur-
er’s recommendations and applied directly to the tissue 
sections; a coverslip was subsequently placed on top and 
sealed using rubber cement. DNA was denatured at 83 °C 
for 5 min and then renatured with FISH probes by over-
night incubation at 37 °C. The following day, slides were 
washed by immersion for 2 min in 0.4× SSC, 0.1% Tween-
20 buffer at 73 °C, followed by 1 min in 2× SSC, 0.1% 
Tween-20 buffer, at room temperature. The sections were 
air dried and mounted in Vectashield medium containing 
the nuclear dye DAPI (H-1200, Vector Laboratories).
Phenotypic analysis of fused Purkinje cells
Fused Purkinje cells in fixed, fluorescently labelled cer-
ebellar slices were identified according to their location 
in the sagittal slice, characteristic morphology and co-
expression of EGFP and calbindin-D28K. Each slice was 
scanned along the entire length of the Purkinje cell layer, 
situated between the granular layer and molecular layer. At 
least 2000 Purkinje cells from each mouse were examined 
to determine the frequency of Purkinje cell heterokary-
ons. The presence of two nuclei in these Purkinje cells 
was confirmed using confocal microscopy to view serial 
sections throughout the whole Purkinje cell soma. The 
frequencies of Purkinje cells expressing SMI-34 in the 
soma or with hypertrophic (enlarged) axons expressing 
SMI-34 were counted, scanning the entire Purkinje cell 
and granular layers.
FISH was also used to visualise nuclear chromosomal 
content of Purkinje cells. For X/Y chromosomal numera-
tion and identification of Polyploid cells, FISH-labelled sec-
tions were viewed using confocal microscopy. Fluorescently 
labelled X and Y probes yielded green and red signals, 
respectively. Using confocal microscopy, cells were again 
scanned throughout the entire cell soma to observe the X/Y 
chromosomal frequency.
The cell soma area was measured in fixed sections stained 
with antibodies to EGFP and/or calbindin-D28K by manu-
ally outlining the perimeter in Z-stacked confocal micro-
scopic images using Image J software (National Institutes 
of Health). Measurements were made of EGFP-positive/cal-
bindin-D28K positive and adjacent or nearby EGFP-negative/
calbindin-D28K positive Purkinje cells (n = ≥ 5 animals, ≥ 10 
cells measured/per animal). ≥ 16 individual cells/group were 
used to compare the soma size of EGFP-positive Purkinje 
cells containing two dispersed nuclei and EGFP-negative 
Purkinje cells with both a dispersed and a compact nucleus.
Quantifying cerebellar inflammation 
and demyelination
CD11b/c was used to identify macrophages/microglia within 
tissue sections. All EGFP or CD11b/c positive cells were 
counted, using at least six randomly assigned fields per slice 
within both the white matter and grey matter regions of the 
cerebellum. The number of EGFP or CD11b/c positive cells 
per  mm2 was subsequently calculated.
The degree of demyelination in both the cerebellar white 
and grey matter (granular layer) was assessed by quantifying 
anti-MBP labelling by optical density. Using at least three 
randomly assigned sagittal cerebellar slices per animal, con-
focal images of MBP immuno-labelled cerebellar sections 
from each animal were processed using Image J and MBP 
density was calculated as a percentage of the total area.
Extracellular recording from Purkinje cells 
and analysis
Individual slices were viewed on a Zeiss FS Axioskop micro-
scope (Carl Zeiss Ltd., Welwyn Garden City, UK) 1–8 h 
after cutting and superfused with standard Krebs–Hense-
leit solution at near physiological temperature (~ 34 ± 1 °C, 
maintained with a home-made Peltier-controlled recording 
chamber). Purkinje cells were readily identified by their 
position in the slice and characteristic size and shape. In 
slices from female mice with EAE, Purkinje cells fused 
with BM-derived cells were identified by EGFP fluores-
cence. Since < 1% of Purkinje cells were EGFP-positive, it 
was rare for such a cell to be at the surface of a slice and 
readily accessible for recording. Therefore, once an EGFP-
positive cell was identified, it was often necessary to remove 
overlying tissue prior to recording. This was achieved with 
a fine stream of extracellular solution from a macropipette 
(tip diameter, ~ 5 µm). Extracellular recordings were made 
from the soma for at least 10 min in loose cell-attached mode 
with low resistance pipettes (1.2–1.9 MΩ, thin-walled boro-
silicate glass; GC150Tf-10, Harvard apparatus; filled with 
extracellular solution). To ensure that spontaneous firing was 
not influenced by the presence of the pipette on the soma, 
we prevented formation of a tight ‘seal’ between the pipette 
and soma by pre-exposing the pipette tip to the tissue in 
the slice [1]. The ‘seal’ resistance was < 9 MΩ. Spontane-
ous electrical activity was recorded in voltage-clamp with 
an Axopatch 200A or 200B amplifier (Axon Instruments, 
Union City, CA). Current recordings were low-pass fil-
tered at 5 kHz (4 pole Bessel filter in the Axopatch 200 A/B 
amplifier) and digitised on-line at 40 kHz with a Cambridge 
Electronic Design (CED) power 1401 A/D interface using 
Spike2 software (v. 6.16) (CED, Cambridge, UK). In slices 
from mice with EAE, recordings were made from EGFP-
positive cells and adjacent or nearby EGFP-negative cells. 
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Recordings were also made from Purkinje cells in slices of 
sex- and age-matched control mice (female, no BMT, no 
EAE induction, 9.5–11.5 months).
Recordings were analysed with CED Spike2 software. 
Three different patterns of firing of control Purkinje cells 
were defined by the presence or absence of distinct, long 
pauses in firing (> 1.6 s), the distribution of interspike inter-
vals (ISI) during firing periods and the shape of plots of 
instantaneous frequency (IF) against time. For tonically fir-
ing cells, the ISI distribution showed a single peak with a 
mean between 8 and 21 ms and a coefficient of variation 
(CV) between 0.08 and 0.80. This tonic category includes 
cells firing persistently in a regular tonic pattern (mean, 
9–21 ms: CV, 0.08–0.21; e.g. see Online Resource 1; Fig. 
S1ai) or a regular tonic pattern interrupted by bursts of firing 
(mean, 8–13 ms; CV, 0.28–0.85; e.g. see Online Resource 
1; Fig. S1aii). For cells firing in a trimodal manner (see 
Online Resource 1; Fig. S1b), there were distinct long 
pauses in firing (1.6–15 s) and the distribution of ISI dur-
ing firing periods showed multiple components. The short-
est ISI (< 10 ms) occurred within bursts and the longer ISI 
(25–50 ms) occurred between bursts, while intermediate ISI 
(~ 20 ms) separated spikes during regular tonic firing. The 
differing ISI resulted in a high CV (0.6–2.4). Cells were 
placed into this category if they showed all three modes of 
firing irrespective of the order; for example, it includes cells 
following a tonic, burst, pause, tonic, burst, pause pattern 
as well as cells following a tonic, burst, tonic, burst, pause 
pattern. For cells classified as firing in an irregular pattern 
(see Online Resource 1 Fig. S1c), spikes occurred as single 
events or in clusters of closely spaced two, three or four 
events. The ISI distribution was broad (2–500 ms) or it had 
two components, in which the first component represented 
intervals between spikes within clusters and the longer com-
ponent represented intervals between clusters. The mean and 
CV ISI values were 15–43 and 0.8–1.3 ms. In some of these 
cells, the firing was separated by distinct pauses in firing 
(7–10 s).
Statistical analysis
Statistical tests were performed using GraphPad Prism (v. 6 
or 7, GraphPad Software Inc, USA). All tests were two-sided; 
values of p < 0.05 were considered statistically significant. 
For histological analysis, at least five independent animals 
from each group were included. Where data were known 
or predicted to violate assumptions for parametric statisti-
cal testing, an equivalent non-parametric test was performed 
(normality was analysed using the Shapiro–Wilk test; une-
qual variances between groups were subsequently analysed 
using either the Bartlett’s test or F test). Data between two 
groups were analysed using paired/unpaired Student’s t tests, 
Wilcoxon matched-pairs signed rank tests or Mann–Whitney 
U tests. Statistical comparisons for more than two groups 
were analysed using either one-way analysis of variance 
(ANOVA) followed by Holm–Sidak’s multiple comparisons 
test or Kruskal–Wallis followed by Dunn’s multiple compari-
son test between groups. Box and whisker plots represent the 
median, upper quartile and lower quartile values (box) and 
the minimum and maximum values (whiskers). For electro-
physiological data, the Chi-squared test was used to compare 
the frequency of different modes of firing. One-way or two-
way ANOVA followed by the Holm–Sidak’s multiple com-
parisons test was used to compare different firing parameters. 
Number of cells is denoted as n. Origin (v. 6 or 7, Microcal, 
Northampton, MA, USA) was used to plot voltage traces.
Results
Bone marrow transplantation leads to robust levels 
of BM chimerism
To enable tracking of BM-derived cells infiltrating the brain, 
we generated BM chimeras by lethally irradiating wild-type 
C57BL/6 mice (to deplete their own BM) and stably recon-
stituting these animals with BM-derived cells expressing 
EGFP (donated by EGFP-expressing C57BL/6 mice, see 
methods) (Fig. 1a; abbreviated in the figures as BMT). All 
chimeric mice showed robust levels of chimerism; 97.1% 
± 2.57 (mean ± SD, n = 8) of mononuclear cells within the 
peripheral blood of transplanted mice were EGFP-positive 
and thus donor-derived (Fig. 1b).
Induction of EAE results in significant cerebellar 
injury
To induce cerebellar injury, inflammation of the CNS was 
triggered with EAE [38]; a widely studied animal model of 
human CNS inflammatory demyelinating diseases, including 
multiple sclerosis. Chimeric mice (n = 15) were immunised 
18 weeks post-transplantation by subcutaneous injection of 
MOG peptide in adjuvant. Following EAE induction, the 
disease was observed to manifest clinically from approxi-
mately 10 days post-immunisation, with paralysis proceed-
ing in a caudal to rostral pattern (beginning with the tail 
and progressing to the hind limbs) and stabilizing at day 17 
(Fig. 1c). In several animals, an additional lack of coordina-
tion was evident, suggesting cerebellar involvement.
Pathologically, ‘classical’ MOG-induced EAE in mice 
is associated with extravasation of activated myelin-
specific T-lymphocytes into the CNS and subsequent 
recruitment of macrophages, which cause focal plaques 
of demyelination associated with both axonal damage and 
neuronal loss [30, 33]. In confirmation, we observed cer-
ebellar white matter loss with cavitation and fragmentation 
912 Acta Neuropathologica (2018) 135:907–921
1 3
of myelin, as indicated by a fall in the density of MBP, in 
the brains of mice with EAE from 10 weeks post-immu-
nisation. These changes were accompanied by extensive 
infiltration into the cerebellum of activated EGFP-positive 
macrophage/microglial cells, which were found to con-
tain cytoplasmic myelin debris (Fig. 1d–f). We observed 
Fig. 1  EGFP-BM chimera formation, EAE induction and detection 
of inflammatory demyelinating lesions in the cerebellar white mat-
ter. a A schematic representation of the experimental design. To form 
EGFP-expressing BM chimeras, recipient mice underwent myeloab-
lative irradiation prior to receiving unfractionated BM cells express-
ing EGFP by tail-vein injection. Mice subsequently underwent EAE 
induction, with MOG (p35-55), and the clinical EAE score was 
monitored daily until animals were euthanised for electrophysiology 
and histological analysis. b Flow cytometric analysis to evaluate the 
level of BM chimerism within mice transplanted with EGFP-BM 
cells. The percentage of peripheral blood mononuclear cells (MNCs) 
positive for EGFP (green peak) was calculated [MNCs with a rela-
tive fluorescence higher than that of MNCs derived from non-trans-
planted wild-type  control mice (white peak)]. c The mean clinical 
score of mice with EAE post immunisation. (0, no disease; 1, flac-
cid tail; 2, hindlimb weakness and/or impaired righting; 3, hindlimb 
paralysis; 4, hind and forelimb paralysis; 5, moribund). d Repre-
sentative images of cells positive for EGFP in cerebellum labelled 
for MBP of BM-transplanted mice (BMT) and BM-transplanted mice 
with EAE (BMT EAE). After EAE, there are more EGFP-positive 
cells, EGFP-positive macrophages detected containing myelin debris 
within their cytoplasm, and patchy loss of MBP expression (demy-
elinating lesions; unlabelled patches). The hatched area in BMT EAE 
refers to the magnified image (i). e An enlarged image showing that 
EGFP-positive cells co-express the microglial/macrophage marker 
CD11b/c in the cerebellum of BMT EAE mice. f Quantification of 
EGFP-positive cells, CD11b/c-positive cells and MBP density within 
the cerebellar white and grey matter in control, BMT and BMT EAE 
mice. **p < 0.01 EGFP cells (f); Mann–Whitney U test. **p < 0.01, 
***p < 0.001 CD11b/c cells (f); one-way ANOVA followed by 
Holm–Sidak’s multiple comparison test. *p < 0.05 MBP levels (f); 
Kruskal–Wallis followed by Dunn’s multiple comparison test. Box 
and whisker plots show median ± quartiles (box), min/max (whisk-
ers). For all tests, n = ≥ 5 per group
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a decrease in the number of Purkinje cells (identified 
by expression of calbindin-D28K [31]) and a significant 
reduction in soma size (Fig. 2a, b), indicating Purkinje 
cell atrophy [24]. (These changes were likely caused not 
only by CNS inflammation, but also by gamma irradiation-
induced injury during myeloablative BMT conditioning 
[44]). There were also rare instances of multifocal loss of 
Purkinje cells (absence of calbindin-D28K labelling) with 
basket cell pinceau remaining in situ, resulting in the for-
mation of ‘empty baskets’ (the axon terminals from bas-
ket cells that typically envelop Purkinje cell soma, appear 
to surround an empty space) (Fig. 2c). In addition, EAE 
caused Purkinje cell axonal thickening and formation of 
axonal torpedoes within the granular layer, indicative of 
injury to the axonal compartment [24] (Fig. 2a, c). Dual-
immunolabelling with calbindin-D28K and SMI-34 (anti-
phosphorylated neurofilament) revealed pathological SMI-
34 accumulation within the Purkinje cell soma, axon and 
dendrites, indicative of abnormally high levels of neuro-
filament phosphorylation [34] (Fig. 2a, c).
Purkinje cells fused with BM‑derived cells in EAE 
animals form binucleate heterokaryons that are 
otherwise morphologically typical of control 
Purkinje cells
Having established that EAE caused cerebellar Purkinje cell 
injury, double immuno-labelling experiments for expression 
of calbindin-D28K and EGFP were carried out to identify 
Purkinje cells that had fused with EGFP-expressing BM-
derived cells in response to EAE and to characterise their 
phenotype. Such cells were scattered throughout the cerebel-
lum of BM chimeric mice and indicated the expression of 
donated BM-derived nuclear transgenes (e.g. EGFP) within 
the host Purkinje cell (Fig. 3a). EGFP-positive Purkinje 
cells occurred at a mean frequency of 0.89% ± 0.41 (± SD, 
n = 10 animals), which, in agreement with previous work 
[20], was almost 20 times higher (p < 0.001; Mann–Whitney 
U test) than the incidence in control transplanted animals 
(0.05% ± 0.07, mean ± SD, n = 5 animals; transplanted with 
EGFP BM-derived cells but without induction of EAE).
Fig. 2  EAE induces Purkinje cell pathology in BM transplanted mice. 
a Quantification of Purkinje cells per mm of the Purkinje cell layer, 
size of Purkinje cell soma, the number of hypertrophic axons or axons 
with spheroid (normalised by Purkinje cell number) and the number 
of SMI-34 positive Purkinje cells in control mice, mice transplanted 
with BM cells (BMT) and mice transplanted with BM cells and EAE 
(BMT EAE). EAE decreased Purkinje cell number and soma size and 
induced cell injury as indicated by the increase in number of hyper-
trophic axons and cells expressing SMI-34. b A 3D laser-scanning 
confocal image depicting calculation of Purkinje cell soma area. c 
Injured Purkinje cells depicted through (i) Purkinje cell loss (empty 
basket; white triangle) and hypertrophic axons (white arrows) and (ii) 
SMI-34 positive Purkinje cells (white arrows) within the cerebellum 
of a BM transplanted mouse with EAE. Statistical comparisons are 
either one-way ANOVA followed by Holm–Sidak’s multiple com-
parison test [Purkinje cells per mm (a)] or Kruskal–Wallis followed 
by Dunn’s multiple comparison test [soma area; hypertrophic axons/
spheroids; SMI-34 positive Purkinje cells (a)]. *p < 0.05. Box and 
whisker plots show median ± quartiles (box), min/max (whiskers). 
For all tests, n = ≥ 5 per group
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The EGFP-positive Purkinje cells showed typical Purkinje 
cell morphology, characterised by extensive dendritic arbo-
risation climbing through the molecular layer toward the 
surface of the cortex and an axon originating at the oppo-
site (basal) pole of the cell soma (within the Purkinje cell 
layer) (Fig. 3b). In-depth confocal evaluation and serial 
reconstruction, by which it was possible to image the vol-
ume of the soma, revealed that EGFP-positive Purkinje cells 
were binucleate (Fig. 4a). The majority (61.5%) of these 
cells contained one large Purkinje cell-like nucleus with dis-
persed chromatin and a large nucleolus, and a second smaller 
nucleus with compact chromatin (Fig. 4b). This nuclear 
phenotype signifies a recent fusion event [41]. The remain-
der contained two Purkinje cell-like nuclei with dispersed 
chromatin, indicative of a more mature fused cell; the donor 
nucleus, identified by its compact chromatin, is thought to 
be reprogrammed to assume the properties of a Purkinje cell 
nucleus [41]. The different origin of each nucleus was veri-
fied with FISH using probes to both X and Y chromosomes. 
This showed that binucleate cells contained a complement 
of sex chromosomes indicative of fusion between a male 
and a female cell (XY + XX or Y + XX karyotype) (Fig. 4c). 
Furthermore, the soma of EGFP-positive Purkinje cells was 
significantly larger than that of adjacent or nearby EGFP-
negative Purkinje cells (that had not undergone fusion) 
located in the same EAE animal, and the soma of fused 
Purkinje cells containing two dispersed nuclei was larger 
than that of fused cells with both a dispersed and a compact 
nucleus (Fig. 4d).
Further analysis revealed that hyper-phosphorylated 
neurofilament in Purkinje cells, detected by SMI-34 immu-
nolabelling, was absent in all EGFP-positive Purkinje cells 
(n = 5 animals, ≥ 10 cells counted/per animal). This indi-
cates that the increase in the number of SMI-34-positive 
Purkinje cells in response to EAE (Fig. 2a, c) reflects SMI-
34 expression by non-fused, EGFP-negative Purkinje cells. 
Previous studies have shown differential degeneration of 
zebrin-positive (Z+) or zebrin-negative (Z−) Purkinje cells 
in mouse models of various cerebellar diseases [18, 36] but 
we found that equal proportions of EGFP-positive cells were 
either Z− (56.9% ± 33.51, mean ± SD, n = 6 animals) or Z+ 
(43.1% ± 33.51, mean ± SD, n = 6 animals) (p = 0.75; paired 
Wilcoxon matched-pairs signed rank test. ≥ 10 cells counted/
per animal) (Fig. 4e), indicating that fusion with BM-derived 
cells did not favour either subtype of Purkinje cell. All fused 
cells examined also expressed the gamma-aminobutyric acid 
(GABA)-synthesizing enzyme GAD within the soma and the 
dendritic arbour, demonstrating maintained synthesis of the 
Purkinje cell neurotransmitter, GABA (Fig. 4f). Furthermore, 
labelling of synaptic terminals with synaptophysin showed that 
synaptic contacts onto the soma and dendrites were maintained 
from, respectively, basket cells and parallel fibres (Fig. 4g). 
Altogether, these results demonstrate that upon fusion with 
BM-derived cells, Purkinje cells are largely both structurally 
and phenotypically indistinguishable (with exception of binu-
cleation) from normal ‘healthy’ Purkinje cells.
Fig. 3  The shape of Purkinje cells fused with BM-derived cells in 
EAE animals is typical of control Purkinje cells. 3D laser-scanning 
confocal images of EGFP-positive Purkinje cells (cells that had fused 
with EGFP-expressing BM-derived cells) within the cerebellum of 
BM transplanted EAE mice. Examples of cells labelled for a EGFP 
or b EGFP plus the fluorescent nuclear stain DAPI, with (right) or 
without (left) the Purkinje cell-specific marker calbindin-D28K. Dou-
ble immunolabelling revealed coexpression of EGFP throughout the 
soma, dendrites and axon in a Purkinje cell (green), amongst Purkinje 
cells positive only for calbindin-D28K (red). EGFP-positive Purkinje 
cells showed typical Purkinje cell morphology; extensive dendritic 
arborisation climbing through the molecular layer toward the surface 
of the cortex and an axon originating at the opposite (basal) pole of 
the cell soma (within the Purkinje cell layer)
915Acta Neuropathologica (2018) 135:907–921 
1 3
Fusion between BM‑derived cells and injured 
Purkinje cells preserves Purkinje cell firing 
properties
In parallel with the analysis of the structure and number of 
Purkinje cells in EAE mice that had or had not fused with 
BM-derived cells infiltrating the brain, we investigated 
how CNS inflammation and degeneration affects the firing 
properties of Purkinje cells and explored the possibility 
that fusion with BM-derived cells mitigates the effects of 
cell injury on electrical activity. Extracellular recordings 
of spontaneous firing were made from EGFP-positive and 
adjacent or nearby EGFP-negative Purkinje cells in the 
same cerebellar slices ex vivo, and their electrical activity 
was compared with that of Purkinje cells in slices from 
‘healthy’ age and gender-matched control animals (female, 
9.5–11.5 months, no BMT, no EAE-induction). For all 
three varieties of Purkinje cells, a minor proportion of 
cells did not fire during at least 10 min of recording. The 
percentage of silent EGFP-negative cells (34.6%; 9/26) 
was approximately double that of silent EGFP-positive 
cells (15.8%; 3/19) or silent control cells (19.4%; 6/31). 
However, these proportions were not statistically differ-
ent [χ2(2, n = 76) = 2.695, p = 0.2598] possibly due to the 
relatively low fusion rate of less than 1% that, in turn, 
resulted in the infrequent occurrence of EGFP-positive 
cells near the surface of the slice that could be accessed 
with a recording electrode.
Fig. 4  Phenotypic characteristics of EGFP-expressing Purkinje cells. 
a Images and b quantification of binucleate EGFP-positive Purkinje 
cells (Purkinje cells that had fused with EGFP-BM-derived cells) 
containing either (i) two Purkinje cell-like nuclei with dispersed chro-
matin (D/D, dispersed/dispersed) or (ii) one Purkinje cell-like nucleus 
and one smaller nucleus with compact chromatin (D/C, dispersed/
compact). Un indicates nuclei that were unclassified in a minority 
of cells. c FISH analysis of male to female BM transplantation high-
lighting a binucleate Purkinje cell containing nuclei (dashed outlines) 
with both a female (X/X) and male (Y/?) karyotype, indicative of a 
fusion event between a male BM-derived cell and an endogenous 
female Purkinje cell. d Soma size of Purkinje cells in BM-trans-
planted mice with EAE (BMT EAE); (left) measurements shown are 
for EGFP-negative Purkinje cells (red), EGFP-positive Purkinje cells 
only (green), and (right) EGFP-positive Purkinje cells sorted accord-
ing to density of nuclear chromatin (D/C, dispersed/compact; D/D, 
dispersed/dispersed). e Images of (i) a zebrin-negative, EGFP-posi-
tive Purkinje cell and (ii) a zebrin-positive, EGFP-positive Purkinje 
cell. f 3D laser scanning confocal images showing extensive GAD 
expression in the (i) soma and (ii) dendrites of an EGFP-positive 
Purkinje cell. g Evidence of synaptophysin-positive pre-synaptic 
boutons (white triangles) on the (i) soma and (ii) dendrites of an 
EGFP-positive Purkinje cell. (White arrows indicate EGFP-negative 
Purkinje cells). **p < 0.01 (d); Mann–Whitney U test. *p < 0.05 (d); 
unpaired t test. Box and whisker plots show median ± quartiles (box), 
min/max (whiskers). For all tests, n = ≥ 5 per group
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Electrically active Purkinje cells showed heterogene-
ity in their firing patterns, in keeping with the previously-
described heterogeneity of Purkinje cell firing in control 
animals [15]. Therefore, to enable comparison of electrical 
activity, we firstly classified the firing patterns in cells from 
control animals into different categories and established the 
relative percentages of cells exhibiting the different patterns. 
The same criteria were then applied to recordings from 
EGFP-negative and EGFP-positive cells in slices from EAE 
animals. The three types of firing identified in control cells 
(see Online Resource 1; Fig. S1) were (1) tonic (character-
ised by the absence of long pauses), (2) trimodal (charac-
terised by long pauses and periods of tonic and burst firing 
which could occur in any order) and (3) irregular (charac-
terised by firing of single spikes or clusters of 2–4 closely 
spaced spikes, at widely varying intervals) (see “Materials 
and methods” for more analytical details).
We found that the three types of firing present in Purkinje 
cells from control animals also occurred in EGFP-negative 
and EGFP-positive Purkinje cells of EAE animals, as illus-
trated in Fig. 5. However, the proportions of cells with the 
different patterns of firing were not the same. Within cer-
ebellar slices from EAE animals, the majority of EGFP-neg-
ative cells (82%) fired in a trimodal pattern compared to only 
31% of EGFP-positive cells (Fig. 6a); conversely, 50% of 
EGFP-positive cells fired tonically and this percentage was 4 
times greater than for EGFP-negative cells (12%). These dif-
ferences do not reflect different lobular locations as record-
ings were made from adjacent or nearby EGFP-positive and 
negative cells (Fig. 6b). Notably, the distribution of EGFP-
positive cells with the different firing patterns was the same 
as for Purkinje cells from control animals (Fig. 6a), which 
were also recorded throughout different cerebellar lobules 
(Fig. 6b). Furthermore, the fraction of time spent by EGFP-
negative, trimodal cells in the three different modes was not 
the same as for EGFP-positive or control trimodal cells. 
Overall, more time was spent in the tonic mode and the aver-
age tonic periods were longer in trimodal EGFP-negative 
cells (Fig. 6c). However, there were no differences in the 
frequency (mean ISI) or regularity of tonic firing (CV ISI) 
by tonic cells or trimodal cells (see Online Resource 1; Fig. 
S2), or in the minimum and maximum frequencies of burst 
firing by trimodal cells (not shown, p > 0.05 for all compari-
sons). These electrophysiological results demonstrate that 
a pathological environment causes an increase in the num-
ber of trimodally firing Purkinje cells and a decrease in the 
number of tonically firing Purkinje cells. This change can be 
prevented by fusion of BM-derived cells with Purkinje cells.
Discussion
This study supports the hypothesis that by fusing with neu-
rons in the adult brain, BM-derived cells can prevent or 
repair pathological changes triggered in mature brain neu-
rons by neuroinflammation. We show that the cell fusion 
in vivo maintains not only the structure and subcellular 
composition of cerebellar Purkinje cells; it also maintains 
the electrical firing properties of these neurons. Our study 
finally establishes a likely functional role for heterotypic cell 
fusion, a process identified more than a decade ago [2, 41] 
and proposed as a mechanism for the existence of Purkinje 
cells with two nuclei, first recognised almost 80 years ago 
[3]. The conservation of normal spontaneous firing typical 
of the original native neuron demonstrates that the heter-
okaryon retains neuronal function, which is to fire action 
potentials and hence transfer information through the neu-
ronal circuitry.
Neuroinflammation induced by EAE caused both struc-
tural and functional abnormalities in cerebellar Purkinje 
cells. There was also an increased incidence (20-fold) of 
fusion between BM-derived cells and Purkinje cells; these 
elevations in fusion are similar to those reported in EAE 
mice by Johansson et al. [20]. Pathologically, we found 
demyelination of Purkinje cell axons in the cerebellar cor-
tex and evidence of injury to both the Purkinje cell axon 
and soma; these changes bear significant resemblance to 
features of multiple sclerosis, where abnormal neurofila-
ment phosphorylation in Purkinje cells and robust Purkinje 
Fig. 5  Heterogenous firing patterns of Purkinje cells that had or had 
not fused with BM-derived cells in EAE mice. a–c Different sponta-
neous firing patterns recorded from three Purkinje cells that had not 
fused with BM-derived cells, identified by lack of EGFP-expression. 
Extracellular recordings were made from Purkinje cells located in 
cerebellar slices ex  vivo. Dissimilar patterns of firing were recog-
nized according to criteria established for Purkinje cells from control 
animals (see Online Resource 1; Fig. S1). a Tonic firing in a regu-
lar pattern; IF frequency is constant (left upper) during a 40 s period 
of extracellular recording (left lower). The regular firing is visible 
in the expanded 1 s fragment of the current trace (middle, indicated 
by filled circle) and the narrow histogram (CV) of ISI with a single 
peak (right, the distribution was derived from 6  min of recording). 
b Trimodal firing; three firing modes (quiet, tonic and bursting) are 
evident in the plot of IF against time (left upper) and the continuous 
extracellular recording (left lower). Tonic and burst firing is evident 
in the expanded 1 s fragments of current traces (middle) and the mul-
tiple components and relatively high CV of the ISI histogram (right, 
generated for a single firing episode). c Irregular firing; in this cell, 
episodes of firing are separated by distinct quiet periods. IF fluctu-
ates widely (left), the expanded current trace reveals the occurrence 
of spikes in clusters (middle) and the histogram of ISI during a fir-
ing episode (right) reveals extremely short and longer ISI within and 
between clusters of spikes. d–f Different spontaneous firing patterns 
recorded in three Purkinje cells that had fused with BM-derived cells, 
identified by EGFP-fluorescence. The images show a fluorescent cell 
identified with an epifluorescence microscope in an unfixed cerebel-
lar slice (left) prior to recording from the soma with an extracellular 
recording pipette (right). Examples of cells firing d tonically, e tri-
modally and f irregularly, identified by the same criteria applied to 
EGFP-negative cells and cells from control animals
◂
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cell loss within lesional areas are reported [5, 11, 25, 34]. 
The shift from a tonic mode to a trimodal mode of firing 
of Purkinje cells in ex vivo cerebellar slices represents an 
increased tendency to burst rather than tonic firing. This is 
in agreement with the altered firing patterns recorded pre-
viously from in vivo Purkinje cells in EAE animals [35]. 
Aberrant expression of the sensory neuron specific sodium 
channel,  Nav1.8, may be partly responsible [35] although 
changes in expression levels of the various ion channels and 
transporters that shape Purkinje cell firing are likely to be 
implicated [5, 7, 11, 16, 17]. It is possible, therefore, that 
fusion with BM-derived cells maintains Purkinje cell fir-
ing and/or interaction with neighbouring cells through nor-
malisation of ion channel, transporter or receptor expres-
sion. This is predicted to occur by nuclear transfer from the 
BM-derived cells and subsequent exposure to transcription 
Fig. 6  The proportions of Purkinje cells with different firing patterns 
are changed in EAE; this change is normalized by fusion with BM-
derived cells. a Different percentages of cells with tonic, trimodal 
and irregular firing patterns recorded in EGFP-negative and EGFP-
positive Purkinje cells (fused with BM-derived cells) in EAE-mice, 
and in Purkinje cells from control animals [χ2(4, n = 58) = 12.42, 
p = 0.0145]. b Locations of recorded cells, colour-coded according to 
the type of firing observed, on a schematic drawing of a sagittal slice 
of mouse cerebellum. For a few recordings (circles next to the draw-
ing) there was no information about their location. Numbers indicate 
different lobules. c Left, fraction of time spent by trimodally firing 
cells in each of three modes, tonic, burst and quiet. EGFP-negative 
cells spend more time in the tonic mode than EGFP-positive cells or 
cells from control animals (*p < 0.05; 2-way ANOVA, Holm-Sidak’s 
multiple comparison test); Right, box plot of mean durations of tonic 
periods in trimodally firing cells. Tonic periods are longer in EGFP-
negative cells (*p < 0.05; ANOVA followed by Holm-Sidak’s multi-
ple comparison test). Box and whisker plots show median ± quartiles 
(box), min/max (whiskers). n values are depicted within graph bars
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factors within the Purkinje cell fusion partner, resulting in 
the expression of donated genes to restore ‘normal’ gene 
expression. A clue that this occurs is the observed trans-
lation of the EGFP gene, donated by the BM-derived cell 
following fusion. Further insight into the genes expressed 
by fused Purkinje cells could be obtained through exploit-
ing species-mismatched BMT (transplantation of rat BM 
into mice [20]). Subsequent single-cell mRNA analysis of 
fused cells, using species-specific primers to genes involved 
in neurophysiological function known to be differentially 
expressed in EAE (e.g. Cacna1a, Scn10a; S100a10 [5, 7, 
11]), may provide key answers. Characterisation of the cor-
rective changes in gene expression and identification of the 
channel or transporter genes involved requires further study.
In response to cerebellar injury, why BM-derived cells 
fuse preferentially with Purkinje cells is unknown. Purkinje 
cells are likely to express membrane-specific molecules ren-
dering them fusogenic. As there is no evidence for Purkinje 
cell generation in adult life [28], the potential evolutionary-
driven capacity to express these molecules, allowing the tar-
geted fusion of BM cells with Purkinje cells to prevent their 
loss, could relate to their unique physiological significance 
in the cerebellum. The notion that cell fusion in the brain 
may have a role in neuronal repair has significant implica-
tions for regenerative medicine. Degeneration of the cer-
ebellum, and particularly Purkinje cells, occurs in numerous 
acquired and inherited neurological disorders [4, 6, 19, 24, 
34, 37]. Moreover, many of these disorders are thought to 
share common pathogenic pathways that result in altered 
intrinsic activity of Purkinje cells [32].
BM-derived cells fusing with Purkinje cells in response to 
inflammation is of particular importance to cerebellar injury, 
as cell fusion may be an immune-mediated phenomenon 
aimed at protecting Purkinje cells against inflammatory or 
toxic insults [21]. As we report here in mice, inflammatory 
disease-associated increases in BM-derived cells fusing with 
Purkinje cells have also been observed in patients who had 
multiple sclerosis [22]. There is also evidence that underly-
ing levels of cerebellar inflammation influence Purkinje cell 
fusion and heterokaryon formation in patients with genetic 
ataxias [24]. Exploiting heterotypic cell fusion as a mode 
of cell rescue, to introduce ‘therapeutic’ genetic material 
to boost neuronal cell survival may, therefore, hold hugely 
valuable implications for a wide range of patients with other-
wise untreatable neurodegenerative or inflammatory disease. 
Indeed, there are equally important implications for aging in 
the CNS and the preservation of highly complex neuronal 
sub-populations.
Whole BM and selected BM-derived haematopoietic and 
mesenchymal stem cell fractions have been studied experi-
mentally with the ultimate purpose of treating cerebellar 
disease [12]. Yet, there are still significant deficiencies in 
our understanding of which precise BM cell therapy protocol 
is most efficacious. Central to this, understanding whether 
selected BM cell populations or the whole BM are required 
to reduce disease activity and effect repair is of paramount 
importance. Understanding whether there are fundamental 
differences in the ‘fusogenic’ properties of different BM cell 
types will help aid the design of future therapeutic trials uti-
lizing transplantation of BM cells in these disorders. Explor-
ing these precise interactions between BM-derived cells and 
Purkinje cells is likely to aid the search for much needed 
novel reparative and regenerative therapeutic approaches 
into ways in which nerve cells can be protected and their 
survival prolonged.
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